<DOC>
	<DOCNO>NCT01544478</DOCNO>
	<brief_summary>This study evaluate long term safety quadrivalent Human Papillomavirus ( HPV ) type 6 , 11 , 16 , 18 vaccine effectiveness prevention cervical intraepithelial neoplasia ( CIN ) , adenocarcinoma situ , cervical cancer relate HPV Japanese woman .</brief_summary>
	<brief_title>V501 Safety Efficacy Study Japanese Women Aged 16 26 Years ( V501-110 )</brief_title>
	<detailed_description />
	<mesh_term>Adenocarcinoma</mesh_term>
	<mesh_term>Uterine Cervical Neoplasms</mesh_term>
	<mesh_term>Carcinoma Situ</mesh_term>
	<mesh_term>Cervical Intraepithelial Neoplasia</mesh_term>
	<mesh_term>Adenocarcinoma Situ</mesh_term>
	<criteria>Healthy Japanese female Not pregnant Screening agree use effective contraception Month 7 study Lifetime history 0 4 male female sexual partner No oral temperature â‰¥37.5 centigrade within 24 hour prior injection Received market HPV vaccine Prior abnormal papanicolaou smear ( PAP ) biopsy show CIN Known history positive test HPV Known history genital wart Received immune globulin blood product within 6 month prior first injection plan receive Month 7 study History splenectomy , know immune disorder , receive immunosuppressive Immunocompromised diagnosed human immunodeficiency virus</criteria>
	<gender>Female</gender>
	<minimum_age>16 Years</minimum_age>
	<maximum_age>26 Years</maximum_age>
	<verification_date>March 2017</verification_date>
</DOC>